Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Volker W, Stieber"'
Autor:
Michael E, Scheurer, Renke, Zhou, Mark R, Gilbert, Melissa L, Bondy, Erik P, Sulman, Ying, Yuan, Yanhong, Liu, Elizabeth, Vera, Merideth M, Wendland, Emad F, Youssef, Volker W, Stieber, Ritsuko R, Komaki, John C, Flickinger, Lawrence C, Kenyon, H Ian, Robins, Grant K, Hunter, Ian R, Crocker, Samuel T, Chao, Stephanie L, Pugh, Terri S, Armstrong
Publikováno v:
Neuro-oncology advances. 4(1)
We sought to identify clinical and genetic predictors of temozolomide-related myelotoxicity among patients receiving therapy for glioblastoma.Patients (23% of patients developed myelotoxicity (Myelotoxicity during concurrent chemoradiation with temoz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::91303e8dafb71bee2f0fc6e0d906fef9
https://pubmed.ncbi.nlm.nih.gov/36299794
https://pubmed.ncbi.nlm.nih.gov/36299794
Autor:
Michael E Scheurer, Renke Zhou, Mark R Gilbert, Melissa L Bondy, Erik P Sulman, Ying Yuan, Yanhong Liu, Elizabeth Vera, Merideth M Wendland, Emad F Youssef, Volker W Stieber, Ritsuko R Komaki, John C Flickinger, Lawrence C Kenyon, H Ian Robins, Grant K Hunter, Ian R Crocker, Samuel T Chao, Stephanie L Pugh, Terri S Armstrong
Publikováno v:
Neuro-Oncology Advances. 4
Background We sought to identify clinical and genetic predictors of temozolomide-related myelotoxicity among patients receiving therapy for glioblastoma. Methods Patients (n = 591) receiving therapy on NRG Oncology/RTOG 0825 were included in the anal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa6d6daf997ef278903e007affaf4560
https://doi.org/10.1093/noajnl/vdac152
https://doi.org/10.1093/noajnl/vdac152
Publikováno v:
Journal of Medical Economics. 22:1006-1013
Purpose: The EF-14 trial demonstrated that adding tumor treating fields (TTFields) to maintenance temozolomide (TMZ) significantly extends progression-free survival (PFS) and overall survival (OS) ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::556d16ce4791e6e556223704da0bb1a3
https://doi.org/10.1080/13696998.2019.1614933
https://doi.org/10.1080/13696998.2019.1614933
Autor:
Cynthia Ménard, Elana Farace, Kurt A. Jaeckle, Anthony L. Asher, Xiomara W. Carrero, Jane H. Cerhan, Fred G. Barker, Richard L. Deming, Karla V. Ballman, Evanthia Galanis, Jesse G. Dixon, Yolanda I. Garces, S. Keith Anderson, Erin Twohy, Stuart H. Burri, Caroline Chung, Paul D. Brown, Volker W. Stieber, Bruce E. Pollock, Jan C. Buckner, Thomas M. Churilla
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 99:1173-1178
To determine whether whole-brain radiation therapy (WBRT) is associated with improved overall survival among non-small cell lung cancer (NSCLC) patients with favorable prognoses at diagnosis.In the N0574 trial, patients with 1 to 3 brain metastases w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d82bb46d57dc39dd9ea557ad1ebeff6
https://doi.org/10.1016/j.ijrobp.2017.07.045
https://doi.org/10.1016/j.ijrobp.2017.07.045
Autor:
Craig Devoe, Jai Grewal, Elise Brownell, Sotirios Bisdas, Robert Cavaliere, Randy L. Jensen, Tina Runk, Diana Dupont-Roettger, Volker W. Stieber
Publikováno v:
Neuro-Oncology. 23:vi70-vi70
BACKGROUND Modified Radiographic Response Assessment in Neuro-Oncology (“mRANO”) criteria based on SPDP form the basis for assessing treatment response in Glioblastoma but are subject to sampling bias and difficulty in differentiating between pse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fcd98b648a6bd5449c43b76a4186ab44
https://doi.org/10.1093/neuonc/noab196.270
https://doi.org/10.1093/neuonc/noab196.270
Autor:
David Roberge, K.S. Anderson, Karla V. Ballman, Caroline Chung, J.B. Ashman, Fred G. Barker, Anthony L. Asher, Joshua D. Palmer, Stuart H. Burri, N.N. Laack, Jean-Paul Bahary, Ian F. Parney, Jeffrey Greenspoon, Jane H. Cerhan, Anthony Whitton, Paul D. Brown, Volker W. Stieber, Eva Galanis, Bruce E. Pollock, Brett Klamer
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:S175-S176
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8f546384785c031aaafef42ad7a28b4
https://doi.org/10.1016/j.ijrobp.2020.07.955
https://doi.org/10.1016/j.ijrobp.2020.07.955
Autor:
David Roberge, Evanthia Galanis, Bruce E. Pollock, Brett Klamer, Karla V. Ballman, Jeffrey Greenspoon, Nadia N. Laack, Jean-Paul Bahary, Jane H. Cerhan, Fred G. Barker, Paul D. Brown, Joshua D. Palmer, Anthony Whitton, Anthony L. Asher, Volker W. Stieber, J.B. Ashman, Stuart H. Burri, Caroline Chung, Ian F. Parney, S. Keith Anderson
Publikováno v:
Neuro Oncol
PURPOSE We investigated the long term impact of SRS and WBRT in two large prospective phase III trials. METHODS Patients with 1–4 BMs +/- resection were randomized to SRS or WBRT. Cognitive deterioration was a drop of >1 standard deviation from bas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17304aa33412d16e93413005199f348a
https://doi.org/10.1093/neuonc/noaa215.168
https://doi.org/10.1093/neuonc/noaa215.168
Autor:
Susanne M. Arnold, Tina Runk, Elise Brownell, Robert Cavaliere, Volker W. Stieber, Alex Zukiwski, Jeffrey Raizer, Stefan Proniuk, Randy L. Jensen, Priya Kumthekar, James Vredenburgh, Craig Devoe, Jai Grewal
Publikováno v:
Neuro Oncol
BACKGROUND AR-67 (formerly DB-67) is a novel 3rd generation camptothecin with improved safety and lipophilicity than current drugs in this class. Safety and efficacy of AR-67 were evaluated in a Phase 2 study in recurrent GBM/gliosarcoma in adult pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8724bbc7d4be0f38e6409080e59057f9
https://europepmc.org/articles/PMC6847938/
https://europepmc.org/articles/PMC6847938/
Autor:
Karla V. Ballman, Volker W. Stieber, Bruce E. Pollock, Paul D. Brown, Ian F. Parney, Stuart H. Burri, Caroline Chung, Jeffrey Greenspoon, David Roberge, Anthony L. Asher, Fred G. Barker, Jean-Paul Bahary, Keith Anderson, Jane H. Cerhan, Nadia N. Laack, Joshua D. Palmer, Brett Klamer, J.B. Ashman, Anthony Whitton, Evanthia Galanis
Publikováno v:
Neuro-oncology Advances
PURPOSE We investigated the long term impact of SRS and WBRT in two large prospective phase III trials. METHODS Patients with 1–4 BMs +/- resection were randomized to SRS or WBRT. Cognitive deterioration was a drop of >1 standard deviation from bas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b27e31b52d82c16f449e3cf14f169f7d
http://europepmc.org/articles/PMC7401389
http://europepmc.org/articles/PMC7401389
BACKGROUND: TTFields plus TMZ treatment significantly increased five-year overall survival results compared to TMZ alone in all patients in the EF-14 trial, with the subgroup of patients age 65 and older showing the greatest survival benefit (hazard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a525ac0a04fc0c292d17a4fa565cfaf
https://europepmc.org/articles/PMC6217146/
https://europepmc.org/articles/PMC6217146/